Gsa Capital Partners LLP Ars Pharmaceuticals, Inc. Comm Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

A detailed history of Gsa Capital Partners LLP transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Gsa Capital Partners LLP holds 98,900 shares of SPRY stock, worth $0. This represents 0.11% of its overall portfolio holdings.

Number of Shares
98,900
Previous 58,979 67.69%
Holding current value
$0
Previous $502,000 185.66%
% of portfolio
0.11%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
N/A
39,921 Added 67.69%
98,900 $1.43 Million
Q2 2024

Aug 15, 2024
SELL
N/A
-69,910 Reduced 54.24%
58,979 $502,000
Q1 2024

May 03, 2024
BUY
N/A
13,545 Added 11.74%
128,889 $0
Q4 2023

Feb 16, 2024
BUY
N/A
115,344 New
115,344 $0
Q1 2023

May 12, 2023
BUY
N/A
10,744 New
10,744 $0
Q2 2022

Aug 09, 2022
SELL
N/A
-22,894 Closed
0 $0
Q1 2022

May 11, 2022
BUY
N/A
11,303 Added 97.52%
22,894 $80,000
Q4 2021

Feb 14, 2022
BUY
N/A
11,591 New
11,591 $77,000

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email